이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Network-1 Technologies 대차 대조표 상태

재무 상태 기준 확인 6/6

Network-1 Technologies 의 총 주주 지분은 $48.4M 이고 총 부채는 $0.0, 이는 부채 대 자기자본 비율을 0% 로 가져옵니다. 총자산과 총부채는 각각 $49.6M 및 $1.2M 입니다.

주요 정보

부채 비율

US$0

부채

이자 보상 비율	n/a
현금	US$43.39m
주식	US$48.43m
총 부채	US$1.18m
총 자산	US$49.62m

최근 재무 상태 업데이트

업데이트 없음

Recent updates

Network-1 Technologies, Inc. (NYSEMKT:NTIP) Investors Should Think About This Before Buying It For Its Dividend

Apr 05

Dividend Investors: Don't Be Too Quick To Buy Network-1 Technologies, Inc. (NYSEMKT:NTIP) For Its Upcoming Dividend

Mar 10

This Insider Has Just Sold Shares In Network-1 Technologies, Inc. (NYSEMKT:NTIP)

Feb 20

Did You Participate In Any Of Network-1 Technologies' (NYSEMKT:NTIP) Fantastic 116% Return ?

Jan 18

Should You Buy Network-1 Technologies, Inc. (NYSEMKT:NTIP) For Its 2.9% Dividend?

Dec 21

This Insider Has Just Sold Shares In Network-1 Technologies, Inc. (NYSEMKT:NTIP)

Nov 24

재무 상태 분석

단기부채: NTIP 의 단기 자산 ( $43.6M )이 단기 부채( $545.0K ).

장기 부채: NTIP 의 단기 자산( $43.6M )이 장기 부채( $639.0K ).

부채 대 자본 내역 및 분석

부채 수준: NTIP 부채가 없습니다.

부채 감소: NTIP 지난 5년간 부채가 없습니다.

부채 범위: NTIP 은 부채가 없으므로 영업현금흐름으로 충당할 필요가 없습니다.

이자 보장: NTIP 에는 부채가 없으므로 이자 지불에 대한 보장은 문제가 되지 않습니다.

Network-1 Technologies 대차 대조표 상태

재무 상태 기준 확인 6/6

주요 정보

최근 재무 상태 업데이트

Recent updates

Upcoming dividend of US$0.05 per share

Dividend of US$0.05 announced

Network-1 Technologies, Inc. Declares Semi-Annual Dividend, Payable on March 29, 2024

Network-1 Technologies, Inc. Declares Semi-Annual Dividend, Payable on September 29, 2023

Network-1 Technologies, Inc. Reports First-Ever Demonstration of Protection Against B. Pertussis Colonization in Phase 2B Human Challenge Study of Bpzel Vaccine

Network-1 Technologies, Inc., Annual General Meeting, Sep 19, 2023

Chairman & CEO exercised options and sold US$77k worth of stock

Network-1 Technologies, Inc. Announces Chief Financial Officer Changes

Insufficient new directors

Chairman & CEO exercised options and sold US$431k worth of stock

Network-1 Technologies, Inc. Declares Semi-Annual Cash Dividend, Payable on September 30, 2022

First half 2022 earnings released: US$0.12 loss per share (vs US$0.36 profit in 1H 2021)

Network-1 Technologies, Inc., Annual General Meeting, Sep 20, 2022

First quarter 2022 earnings released: US$0.055 loss per share (vs US$0.39 profit in 1Q 2021)

Insufficient new directors

Full year 2021 earnings released: EPS: US$0.59 (vs US$0.071 loss in FY 2020)

Upcoming dividend of US$0.05 per share

Network-1 Technologies, Inc. Declares Semi-Annual Cash Dividend, Payable on March 24, 2022

Third quarter 2021 earnings released: EPS US$0.28 (vs US$0.07 in 3Q 2020)

Insider recently sold US$539k worth of stock

First quarter 2021 earnings released: EPS US$0.39 (vs US$0.056 loss in 1Q 2020)

Insider recently sold US$129k worth of stock

Network-1 Technologies, Inc. (NYSEMKT:NTIP) Investors Should Think About This Before Buying It For Its Dividend

Full year 2020 earnings released: US$0.071 loss per share (vs US$0.075 loss in FY 2019)

Insider recently sold US$104k worth of stock

Dividend Investors: Don't Be Too Quick To Buy Network-1 Technologies, Inc. (NYSEMKT:NTIP) For Its Upcoming Dividend

Upcoming Dividend of US$0.05 Per Share

New 90-day low: US$3.00

Insider recently sold US$225k worth of stock

This Insider Has Just Sold Shares In Network-1 Technologies, Inc. (NYSEMKT:NTIP)

New 90-day high: US$3.85

Did You Participate In Any Of Network-1 Technologies' (NYSEMKT:NTIP) Fantastic 116% Return ?

New 90-day high: US$3.57

Insider recently sold US$83k worth of stock

Should You Buy Network-1 Technologies, Inc. (NYSEMKT:NTIP) For Its 2.9% Dividend?

Insider recently sold US$94k worth of stock

New 90-day high: US$3.14

This Insider Has Just Sold Shares In Network-1 Technologies, Inc. (NYSEMKT:NTIP)

Insider recently sold US$300k worth of stock

New 90-day high: US$3.09

Third quarter 2020 earnings released: EPS US$0.07

New 90-day high: US$3.02

Network-1 Technologies, Inc. Announces Court Overturns District Court Judgment of Non-Infringement in its Litigation with Hewlett-Packard

Iliad Biotechnologies, Llc Presented Positive Topline Phase 2B Trial Results of Its Lead Pertussis Vaccine

Insider recently sold US$229k worth of stock

New 90-day high: US$2.47

Upcoming Dividend of US$0.05 Per Share

First half earnings released

재무 상태 분석

부채 대 자본 내역 및 분석

대차 대조표

건강한 기업 발견하기